|
Volumn 42, Issue 3, 2010, Pages 946-947
|
Unplanned readmission within 1 year after heart transplantation in Taiwan
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
MONOCLONAL ANTIBODY;
TACROLIMUS;
ARTICLE;
BIOPSY;
FOLLOW UP;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HOSPITAL READMISSION;
HUMAN;
IMMUNOLOGY;
PATHOLOGY;
PATIENT CARE PLANNING;
PERICARDIAL EFFUSION;
RETROSPECTIVE STUDY;
STATISTICS;
TAIWAN;
TIME;
ANTIBODIES, MONOCLONAL;
ANTILYMPHOCYTE SERUM;
BIOPSY;
CYCLOSPORINE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
PATIENT CARE PLANNING;
PATIENT READMISSION;
PERICARDIAL EFFUSION;
RECOMBINANT FUSION PROTEINS;
RETROSPECTIVE STUDIES;
TACROLIMUS;
TAIWAN;
TIME FACTORS;
|
EID: 77955499374
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.02.053 Document Type: Conference Paper |
Times cited : (14)
|
References (5)
|